ResMed Inc.

Historical 13F Holders

Symbol
RMD
CUSIP
761152107
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 761152107 since 12/18/2024, newest first.

Filer % of Class Filed
AustralianSuper Pty Ltd 13G 5.7% 8/7/2026
Event 6/30/2026
Vanguard Portfolio Management LLC 13G 5.4% 4/29/2026
Event 3/31/2026
Vanguard Capital Management LLC 13G 8.2% 4/29/2026
Event 3/31/2026
Vanguard Group Inc 13G/A Amendment 14 0% 3/27/2026
Event 3/13/2026
Vanguard Group Inc 13G/A Amendment 13 13.7% 10/30/2025
Event 9/30/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 27 225 k $49.2 M
2026 Q2 934 144 M $19.7 B
2026 Q1 980 97.7 M $21.8 B
2025 Q4 994 97.4 M $23.5 B
2025 Q3 1,007 92.6 M $25.3 B
2025 Q2 973 93.4 M $24.1 B
2025 Q1 930 94.4 M $21.1 B
2024 Q4 925 90.9 M $20.8 B
2024 Q3 865 88.5 M $21.5 B
2024 Q2 829 90.7 M $17.4 B
2024 Q1 772 88.5 M $17.5 B
2023 Q4 734 84.4 M $14.5 B
2023 Q3 704 88.3 M $13.0 B
2023 Q2 760 95.7 M $20.8 B
2023 Q1 705 95.9 M $21.0 B
2022 Q4 755 102 M $21.3 B
2022 Q3 697 96.8 M $21.2 B
2022 Q2 701 96.7 M $20.4 B
2022 Q1 716 98.1 M $23.8 B
2021 Q4 755 94.9 M $24.7 B
2021 Q3 717 96.4 M $25.4 B
2021 Q2 695 97.1 M $23.9 B
2021 Q1 690 99.4 M $19.3 B
2020 Q4 701 102 M $22.0 B
2020 Q3 665 101 M $17.3 B
2020 Q2 627 103 M $19.7 B
2020 Q1 631 99.1 M $14.6 B
2019 Q4 599 100 M $15.5 B
2019 Q3 568 97.0 M $13.1 B
2019 Q2 524 97.1 M $11.8 B
2019 Q1 510 97.9 M $10.2 B
2018 Q4 534 100 M $11.4 B
2018 Q3 531 97.9 M $11.3 B
2018 Q2 491 93.1 M $9.64 B
2018 Q1 471 90.7 M $8.93 B
2017 Q4 438 89.6 M $7.59 B
2017 Q3 385 88.9 M $6.85 B
2017 Q2 359 86.8 M $6.76 B
2017 Q1 396 88.8 M $6.39 B
2016 Q4 387 89.0 M $5.52 B
2016 Q3 398 90.0 M $5.83 B
2016 Q2 381 87.4 M $5.53 B
2016 Q1 388 83.6 M $4.83 B
2015 Q4 376 83.8 M $4.50 B
2015 Q3 331 77.8 M $3.96 B
2015 Q2 332 74.6 M $4.20 B
2015 Q1 347 73.6 M $5.27 B
2014 Q4 332 75.8 M $4.26 B
2014 Q3 323 72.8 M $3.59 B
2014 Q2 335 78.9 M $3.99 B
2014 Q1 344 80.1 M $3.58 B